	Agenda For Symposium times and other information, Read More

	Symposium Speakers For a list of the speakers, Read More

	History of Philadelphia Chromosome For a history of the seminal discovery, Read More

	Related Links & Timeline For useful links and a timeline, Read More

The study of the Philadelphia Chromosome has provided essential insights into the role of chromosome changes in cancer. The initial discovery of this abnormal chromosome and its association with chronic myeloid leukemia sparked the search for additional abnormalities that might consistently correlate with particular types of leukemia, lymphoma or other tumors.

-Janet Rowley, University of Chicago, in the Fox Chase Cancer Center publication, Special Edition

Speakers & Honorary Guests

Jeff Boyd, PhD Executive Director, Institute of Personalized Medicine, The Robert C. Young, MD Chair in Cancer Research Fox Chase Cancer Center, Philadelphia, PA	Jennifer J.D. Morrissette, PhD, FACMG Scientific Director, Clinical Cancer Cytogenetics, University of Pennsylvania, Philadelphia, PA
H. Sharat Chandra, PhD Professor Emeritus, Indian Institute of Science; Honorary Director, Centre for Human Genetics, Bangalore, India	Peter C. Nowell, MD Gaylord and Mary Louise Harnwell Emeritus Professor of Pathology and Laboratory Medicine, University of Pennsylvania, School of Medicine, Philadelphia, PA
Brian J. Druker, MD Director, Oregon Health & Science University, Knight Cancer Institute, JELD-WEN Chair of Leukemia Research, Investigator, Howard Hughes Medical Institute Portland, OR	Janet D. Rowley, MD Blum-Riese Distinguished Service Professor of Medicine, Molecular Genetics & Cell Biology, Human Genetics, The University of Chicago Chicago, IL
Emeritus Professor John M. Goldman, DM, FRCP, FRCPath, FMedSci Senior Research Investigator, Division of Investigative Science, Imperial College London, London, United Kingdom	Charles L. Sawyers, MD Investigator, Howard Hughes Medical Institute Chairman, Human Oncology & Pathogenesis Program Memorial Sloan-Kettering Cancer Center, New York, NY
Nora C. Heisterkamp, PhD Professor of Pediatrics and Pathology, Division of Hematology-Oncology, Children’s Hospital of Los Angeles Los Angeles, Ca	William R. Sellers, MD Vice President & Global Head of Oncology Novartis Institutes of BioMedical Research, Inc. Cambridge, MA
Mrs. David A. (Alice) Hungerford, BA ECRI Institute, Plymouth Meeting, PA Nicholas B. Lydon, PhD Granite BioPharma LLC Jackson Hole, WY	Joseph R. Testa, PhD Carol & Kenneth E. Weg Chair in Human Genetics, Co-Director, Cancer Biology Program, Co-Leader, Personalized Kidney Cancer Therapy Keystone Program, Fox Chase Cancer Center, Philadelphia, PA
Felix Mitelman, MD, PhD Professor, Department of Clinical Genetics, University Hospital, Lund, Sweden	Owen N. Witte, MD Investigator, Howard Hughes Medical Institute Director, Broad Stem Cell Research Center at University of California, Los Angeles Howard Hughes Medical Institute, UCLA Los Angeles, CA